GAABRYDA
Live / Registered — Registered (as of 28 Nov 2023)
What this means for you
Registered since 28 Nov 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90232607
- Registration number
- 7231187
- Mark type
- Stylized text
- Filed
- 02 Oct 2020
- Published for opposition
- 13 Apr 2021
- Registered
- 28 Nov 2023
- Attorney of record
- Keith Barritt
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of seizures and epilepsy, status epilepticus, encephalopathies, neurodegenerative disease, cerebrovascular disease, movement disorders, traumatic brain injury and other neurologic conditions, substance abuse, substance withdrawal, dementia, delirium, schizophrenia, bipolar disorder, psychosis, depression, and other psychiatric conditions
Owner
- Marinus Pharmaceuticals, Inc., Radnor, PA, US
- Marinus Pharmaceuticals, Inc., Radnor, PA, US
- Marinus Pharmaceuticals, Inc., Radnor, PA, US
Prosecution history
- 28 Nov 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Nov 2023 — REGISTERED-PRINCIPAL REGISTER
- 27 Oct 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 26 Oct 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 12 Oct 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 28 Sept 2023 — USE AMENDMENT FILED
- 10 Oct 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 28 Sept 2023 — TEAS STATEMENT OF USE RECEIVED
- 02 Jun 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 May 2023 — SOU EXTENSION 4 GRANTED
- 31 May 2023 — SOU EXTENSION 4 FILED
- 31 May 2023 — SOU TEAS EXTENSION RECEIVED
- 10 Nov 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Nov 2022 — SOU EXTENSION 3 GRANTED
- 08 Nov 2022 — SOU EXTENSION 3 FILED